31 related articles for article (PubMed ID: 19448394)
1. Inhibition of TRAIL-induced apoptosis and forced internalization of TRAIL receptor 1 by adenovirus proteins.
Tollefson AE; Toth K; Doronin K; Kuppuswamy M; Doronina OA; Lichtenstein DL; Hermiston TW; Smith CA; Wold WS
J Virol; 2001 Oct; 75(19):8875-87. PubMed ID: 11533151
[TBL] [Abstract][Full Text] [Related]
2. Conditionally replicating adenovirus improves gene replication efficiency and anticancer effect of E1-deleted adenovirus carrying TRAIL in head and neck squamous cell carcinoma.
Shim SH; Lee CT; Hun Hah J; Lee JJ; Park SW; Heo DS; Sung MW
Cancer Sci; 2010 Feb; 101(2):482-7. PubMed ID: 19922505
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus E3-6.7K protein is required in conjunction with the E3-RID protein complex for the internalization and degradation of TRAIL receptor 2.
Lichtenstein DL; Doronin K; Toth K; Kuppuswamy M; Wold WS; Tollefson AE
J Virol; 2004 Nov; 78(22):12297-307. PubMed ID: 15507617
[TBL] [Abstract][Full Text] [Related]
4. Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor alpha-inducible cellular protein containing leucine zipper domains.
Li Y; Kang J; Horwitz MS
Mol Cell Biol; 1998 Mar; 18(3):1601-10. PubMed ID: 9488477
[TBL] [Abstract][Full Text] [Related]
5. Disruption of NBS1/MRN Complex Formation by E4orf3 Supports NF-κB That Licenses E1B55K-Deleted Adenovirus-Infected Cells to Accumulate DNA>4n.
Almuzaini N; Moore M; Robert-Guroff M; Thomas MA
Microbiol Spectr; 2022 Feb; 10(1):e0188121. PubMed ID: 35019694
[TBL] [Abstract][Full Text] [Related]
6. Targeted and shielded adenovectors for cancer therapy.
Hedley SJ; Chen J; Mountz JD; Li J; Curiel DT; Korokhov N; Kovesdi I
Cancer Immunol Immunother; 2006 Nov; 55(11):1412-9. PubMed ID: 16612598
[TBL] [Abstract][Full Text] [Related]
7. YB-1-based oncolytic virotherapy in combination with CD47 blockade enhances phagocytosis of pediatric sarcoma cells.
von Ofen AJ; Thiel U; Eck J; Gassmann H; Thiede M; Hauer J; Holm PS; Schober SJ
Front Oncol; 2024; 14():1304374. PubMed ID: 38357194
[TBL] [Abstract][Full Text] [Related]
8. Understanding the Neurotrophic Virus Mechanisms and Their Potential Effect on Systemic Lupus Erythematosus Development.
Uribe FR; González VPI; Kalergis AM; Soto JA; Bohmwald K
Brain Sci; 2024 Jan; 14(1):. PubMed ID: 38248274
[TBL] [Abstract][Full Text] [Related]
9. Adenoviral gene therapy in hepatocellular carcinoma: a review.
Lyra-González I; Flores-Fong LE; González-García I; Medina-Preciado D; Armendáriz-Borunda J
Hepatol Int; 2013 Mar; 7(1):48-58. PubMed ID: 26201621
[TBL] [Abstract][Full Text] [Related]
10. Homologous recombination-based adenovirus vector system for tumor cell-specific gene delivery.
Lu Q; Ye X; Liu F; Zhao Y; Qin J; Liang M; Fang C; Chen HZ
Cancer Biol Ther; 2013 Aug; 14(8):728-35. PubMed ID: 23792576
[TBL] [Abstract][Full Text] [Related]
11. Desipramine induces apoptosis in rat glioma cells via endoplasmic reticulum stress-dependent CHOP pathway.
Ma J; Qiu Y; Yang L; Peng L; Xia Z; Hou LN; Fang C; Qi H; Chen HZ
J Neurooncol; 2011 Jan; 101(1):41-8. PubMed ID: 20549303
[TBL] [Abstract][Full Text] [Related]
12. Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model.
El-Shemi AG; Ashshi AM; Na Y; Li Y; Basalamah M; Al-Allaf FA; Oh E; Jung BK; Yun CO
J Exp Clin Cancer Res; 2016 May; 35():74. PubMed ID: 27154307
[TBL] [Abstract][Full Text] [Related]
13. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
[TBL] [Abstract][Full Text] [Related]
14. Subversion of host defense mechanisms by adenoviruses.
Burgert HG; Ruzsics Z; Obermeier S; Hilgendorf A; Windheim M; Elsing A
Curr Top Microbiol Immunol; 2002; 269():273-318. PubMed ID: 12224514
[TBL] [Abstract][Full Text] [Related]
15. Functions and mechanisms of action of the adenovirus E3 proteins.
Lichtenstein DL; Toth K; Doronin K; Tollefson AE; Wold WS
Int Rev Immunol; 2004; 23(1-2):75-111. PubMed ID: 14690856
[TBL] [Abstract][Full Text] [Related]
16. Influence of E3 region on conditionally replicative adenovirus mediated cytotoxicity in hepatocellular carcinoma cells.
Lu Q; Yu DH; Fang C; Liu F; Ye X; Zhao Y; Qin J; Guo XK; Liang M; Hu F; Chen HZ
Cancer Biol Ther; 2009 Jun; 8(12):1125-32. PubMed ID: 19448394
[TBL] [Abstract][Full Text] [Related]
17. Conditionally replicative adenovirus vector carrying TRAIL gene for enhanced oncolysis of human hepatocellular carcinoma.
Ye X; Lu Q; Zhao Y; Ren Z; Ren XW; Qiu QH; Tong Y; Liang M; Hu F; Chen HZ
Int J Mol Med; 2005 Dec; 16(6):1179-84. PubMed ID: 16273304
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
